PETVIVO HOLDINGS INC (PETV) Stock Price, Forecast & Analysis
USA - NASDAQ:PETV - US7168174081 - Common Stock
PETV Key Statistics, Chart & Performance
The current stock price of PETV is 0.969 USD. In the past month the price decreased by -10.28%. In the past year, price decreased by -64.63%.
PETV Latest News, Press Relases and Analysis
PETV Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| ABT | ABBOTT LABORATORIES | 25.23 | 219.11B | ||
| ISRG | INTUITIVE SURGICAL INC | 66.92 | 206.56B | ||
| BSX | BOSTON SCIENTIFIC CORP | 34.21 | 149.52B | ||
| SYK | STRYKER CORP | 26.96 | 135.73B | ||
| IDXX | IDEXX LABORATORIES INC | 56.27 | 56.77B | ||
| BDX | BECTON DICKINSON AND CO | 12.6 | 52.06B | ||
| EW | EDWARDS LIFESCIENCES CORP | 32.72 | 49.36B | ||
| RMD | RESMED INC | 25.26 | 36.50B | ||
| GEHC | GE HEALTHCARE TECHNOLOGY | 16.01 | 33.55B | ||
| PODD | INSULET CORP | 70.1 | 22.55B | ||
| DXCM | DEXCOM INC | 29.48 | 21.51B | ||
| ZBH | ZIMMER BIOMET HOLDINGS INC | 10.97 | 17.58B |
Related stock screener links
About PETV
Company Profile
PetVivo Holdings, Inc. is a veterinary biotech and biomedical device company. The company is headquartered in Edina, Minnesota and currently employs 25 full-time employees. The company went IPO on 2012-07-10. The firm is focused on the manufacturing, commercialization, and licensing of medical devices and therapeutics for animals. The Company’s lead product Spryng with OsteoCushion Technology, is a veterinarian-administered, intraarticular injection for the management of lameness and other joint afflictions, such as osteoarthritis in dogs and horses. The firm is primarily engaged in the business of commercializing and licensing products in the veterinary market to treat and/or manage afflictions of companion animals, such as dogs and horses. Its products are derived from biomaterials that simulate a body’s cellular tissue by virtue of their reliance upon natural protein and carbohydrate compositions, which incorporate such tissue building blocks as collagen, elastin, and proteoglycans such as heparin. The firm has a pipeline of therapeutic devices for both veterinary and human clinical applications.
Company Info
PETVIVO HOLDINGS INC
5251 Edina Industrial Blvd
Edina MINNESOTA US
CEO: John Lai
Employees: 25
Phone: 19522174952
PETVIVO HOLDINGS INC / PETV FAQ
What does PETV do?
PetVivo Holdings, Inc. is a veterinary biotech and biomedical device company. The company is headquartered in Edina, Minnesota and currently employs 25 full-time employees. The company went IPO on 2012-07-10. The firm is focused on the manufacturing, commercialization, and licensing of medical devices and therapeutics for animals. The Company’s lead product Spryng with OsteoCushion Technology, is a veterinarian-administered, intraarticular injection for the management of lameness and other joint afflictions, such as osteoarthritis in dogs and horses. The firm is primarily engaged in the business of commercializing and licensing products in the veterinary market to treat and/or manage afflictions of companion animals, such as dogs and horses. Its products are derived from biomaterials that simulate a body’s cellular tissue by virtue of their reliance upon natural protein and carbohydrate compositions, which incorporate such tissue building blocks as collagen, elastin, and proteoglycans such as heparin. The firm has a pipeline of therapeutic devices for both veterinary and human clinical applications.
Can you provide the latest stock price for PETVIVO HOLDINGS INC?
The current stock price of PETV is 0.969 USD. The price decreased by -7% in the last trading session.
Does PETV stock pay dividends?
PETV does not pay a dividend.
How is the ChartMill rating for PETVIVO HOLDINGS INC?
PETV has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 1 out of 10.
When does PETVIVO HOLDINGS INC (PETV) report earnings?
PETVIVO HOLDINGS INC (PETV) will report earnings on 2024-06-27, after the market close.
Who owns PETVIVO HOLDINGS INC?
You can find the ownership structure of PETVIVO HOLDINGS INC (PETV) on the Ownership tab.
PETV Technical Analysis
PETV Fundamental Analysis
ChartMill assigns a fundamental rating of 1 / 10 to PETV. PETV may be in some trouble as it scores bad on both profitability and health.
PETV Financial Highlights
Over the last trailing twelve months PETV reported a non-GAAP Earnings per Share(EPS) of -0.81. The EPS decreased by -6.65% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -292.88% | ||
| ROE | -1187.69% | ||
| Debt/Equity | 0.16 |
PETV Forecast & Estimates
7 analysts have analysed PETV and the average price target is 7.14 USD. This implies a price increase of 636.84% is expected in the next year compared to the current price of 0.969.